Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
NCT04523727Phase 3Suspended
- Sponsor
- Keryx Biopharmaceuticals, Inc.
- Start
- Jun 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric citrate in hyperphosphatemia, sponsored by Keryx Biopharmaceuticals, Inc.. Started Jun 2022; status: suspended.
02
Drugs
ferric citrate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT04523727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04523727.